Perseus Therapeutics Announces Development of TSLP Antibody for Prevention of Hair Loss in Cancer Patients and Treatment of Inflammatory Diseases with well-known CRO partner [Yahoo! Financ...
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
the development of a novel thymic stromal lymphopoietin (TSLP) antibody aimed at preventing hair loss in cancer patients and treating a range of inflammatory diseases, including asthma. TSLP antibodies have recently gained significant attention in the medical and pharmaceutical communities. These antibodies have shown potential in addressing various inflammatory and allergic conditions, driven by their promising efficacy data and the unmet medical needs they aim to fulfill. Several companies and research groups are actively exploring TSLP antibodies, with notable developments including: AstraZeneca and Amgen have developed Tezepelumab, the first-in-class anti-TSLP monoclonal antibody approved for severe asthma treatment. Johnson & Johnson acquired Proteologix to access its bispecific antibody targeting TSLP and IL-13. Blackstone has launched Uniquity to advance Merck's Phase 2 high potency TSLP antibody. Innovent Biologics is conducting a Phase I study on IBI3002, a dual-f
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]Yahoo! Finance
- Adobe Inc. (NASDAQ:ADBE) Q2 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D [Yahoo! Finance]Yahoo! Finance
- AstraZeneca CFO: 'We've come a long way in our oncology portfolio' [Yahoo! Finance Canada]Yahoo! Finance Canada
- AstraZeneca CFO: 'We've come a long way in our oncology portfolio' Updated Thu, Jun 13, 2024, 5:20 PM GMT+2 2 min read 0 In this article: AstraZeneca PLC (AZN) NasdaqGS - Nasdaq Real Time Price (USD) 79.07 -1.00 (-1.26%) As of 11:24AM EDT . Market openAcquire Media Monitor
AZN
Sec Filings
- 6/12/24 - Form 6-K
- 6/4/24 - Form 6-K
- 6/4/24 - Form 25-NSE
- AZN's page on the SEC website